Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer
Status:
Completed
Trial end date:
2016-03-16
Target enrollment:
Participant gender:
Summary
RATIONALE: Morphine may reduce pain in patients who have undergone radiofrequency ablation to
remove bone metastases.
PURPOSE: This phase II trial is studying how well morphine works after radiofrequency
ablation of painful bone metastases in patients with cancer.